Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2006
03/15/2006EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups
03/15/2006EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/15/2006CN1747958A Pyrimidines, methods for the production thereof, and use thereof
03/15/2006CN1747950A 2-(1h-indazole-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
03/15/2006CN1747936A Substituted azole derivatives as therapeutic agents
03/15/2006CN1747730A Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
03/15/2006CN1746167A 2-pyrimidine oxy-benzoic acid [2-(pyrimidine amino methyl)]benester compound, its preparation and use thereof
03/15/2006CN1746166A Hexahydro-phthalmide compound, its preparation and use thereof
03/15/2006CN1245660C Color coupler for forming dye, silver halide photosensitive material and azomethine dyes compounds
03/15/2006CN1245385C Indole and dihydroindole derivatives
03/15/2006CN1245381C Phenylglycine derivatives
03/14/2006US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis
03/14/2006US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction
03/14/2006US7012073 Quinoline derivatives
03/14/2006CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/14/2006CA2357687C New pyridazine endothelin antagonists
03/14/2006CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
03/14/2006CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors
03/14/2006CA2239547C Benzazepine derivatives with vasopressin agonistic activity
03/14/2006CA2237005C Quinazoline derivatives
03/09/2006WO2006026135A2 Substituted biaryl piperazinyl-pyridine analogues
03/09/2006WO2006024837A1 Isoindolin-1-one derivatives
03/09/2006WO2006024823A1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
03/09/2006WO2006024121A1 Use of n-phenylpiperazine derivatives and pharmaceutical compositions containing them
03/09/2006WO2006004924A3 Imidazolo-related compounds, compositions and methods for their use
03/09/2006WO2006000327A3 Triazinyl flavonate brighteners
03/09/2006WO2005091697A3 Thiourea compositions and uses thereof
03/09/2006WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
03/09/2006WO2003103598A3 Amidine derivatives for treating amyloidosis
03/09/2006US20060052615 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
03/09/2006US20060052609 Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
03/09/2006US20060052606 Factor xa Inhibitors
03/09/2006US20060052604 Process for the Preparation of Pyrimidine Compounds
03/09/2006US20060052600 Amino-functional chalcones
03/09/2006US20060052598 Triazine compounds and their use in forming multidimensional libraries for affinity chromatography
03/09/2006US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands
03/09/2006US20060052421 Conjugation agent
03/09/2006US20060052417 N3-((1-(2-Oxo-2-(phenylamino)ethyl)-4-piperidyl)methyl)- 1-(1-methylethyl)-1H-indazole-3-carboxamide; antiarthritic agents; rheumatic diseases; osteoarthritis; fibromyaleia;anticarcinogenic agents, pain; neuropathic pain; immunoincompetance; trauma; antiischemic agents; multiple sclerosis
03/09/2006US20060052415 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form
03/09/2006US20060052411 Immunosuppressants, analgesics, antiinflammatory agents
03/09/2006US20060052408 Cyclopropyl compounds as ccr5 antagonists
03/09/2006US20060052398 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
03/09/2006US20060052396 Arylamines for the treatment of conditions associated with gsk-3
03/09/2006US20060052395 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects
03/09/2006US20060052394 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects
03/09/2006US20060052392 Isoindoline derivative
03/09/2006US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
03/09/2006US20060052384 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia
03/09/2006US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
03/09/2006US20060052378 Psychological disorders; analgesics; eating disorders; drug abuse; 4-(8-chloro-naphthalen-2-yl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; 7-(6-methoxy-pyrazin-2yl)-2-methyl-4-(naphthalene-2-yl)-1,2,3,4-tetrahydroisoquinoline; treating amide intermediates with sodium borohydride
03/09/2006US20060052375 Bis-alkylbenzylamines
03/09/2006US20060052374 Amino-tetrazole analogues and methods of use
03/09/2006US20060052366 Pyridine derivatives as fungicidal compounds
03/09/2006US20060052365 Protease inhibitors
03/09/2006US20060052360 Compounds, compositions and methods
03/09/2006US20060052359 Microbiocides; bactericides
03/09/2006US20060052349 Pyrrolo-naphthyl acids and methods for using them
03/09/2006US20060052345 Quinazolinone compounds as calcilytics
03/09/2006US20060052314 Pharmaceutical combination
03/09/2006US20060051758 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
03/09/2006CA2578955A1 Isoindolin-1-one derivatives
03/09/2006CA2578746A1 Chemical compounds
03/09/2006CA2578630A1 Pyrimidinylimidazoles as tgf-beta inhibitors
03/09/2006CA2578628A1 Pyrimidinylpyrazoles as tgf-beta inhibitors
03/09/2006CA2578441A1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
03/09/2006CA2577398A1 Urea derivatives as calcium channel blockers
03/09/2006CA2577301A1 Substituted biaryl piperazinyl-pyridine analogues
03/09/2006CA2577275A1 Quinazolinone derivatives and their use as b-raf inhibitors
03/09/2006CA2576988A1 Androgen receptor modulators
03/09/2006CA2576717A1 Pyrrole derivatives, their preparation and their therapeutic use
03/08/2006EP1632489A1 5-(1,1'-Biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use.
03/08/2006EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
03/08/2006EP1631567A2 Heterocyclic n-aryl carboxamides as cytokine inhibitors
03/08/2006EP1631566A1 2-anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors
03/08/2006EP1631554A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
03/08/2006EP1631546A1 Sustituted indoline and indole derivatives
03/08/2006EP1631544A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
03/08/2006EP1631292A1 4-anilino-quinazoline derivatives as antiproliferative agents
03/08/2006EP1445252B1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
03/08/2006EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
03/08/2006EP1176959B1 Novel prolines as antimicrobial agents
03/08/2006EP0948327B1 Antidiabetic agents
03/08/2006CN1745082A Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
03/08/2006CN1745077A 促旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/08/2006CN1745076A Malonamide derivatives as gamma-secretase inhibitors
03/08/2006CN1745074A 5-HT receptor ligands and uses thereof
03/08/2006CN1745070A 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
03/08/2006CN1745063A Compound inhibiting dipeptidyl peptidase iv
03/08/2006CN1744894A 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitor for the treatment of cancer
03/08/2006CN1244666C Fluorescent maleimides and uses thereof
03/08/2006CN1244577C 4-phenyl-peiperazinyl,-piperidinyl and -tetrahydropyridyl derivatives
03/08/2006CN1244565C New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
03/08/2006CN1244558C 1,2-hydrindene or indoline derivative
03/07/2006US7009048 Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
03/07/2006US7008959 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders
03/07/2006US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors
03/07/2006US7008946 CCR5 antagonists useful for treating AIDS
03/07/2006US7008945 Amide derivatives
03/07/2006US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/07/2006US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient